Mapping the virus: nationwide study seeks to uncover true COVID-19 spread
NCT ID NCT04658121
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study aims to estimate how many people in various US communities have or have had the SARS-CoV-2 virus. Researchers will test blood and nasal swab samples from over 26,000 adults and children living in senior facilities, attending outpatient clinics, or residing in select neighborhoods. The findings will help determine the best locations for future COVID-19 treatment and prevention trials.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify the best communities for testing new COVID-19 treatments and vaccines.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly benefit participants. Results depend on accurate testing and community participation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
26,211 people
The number who actually took part.
- Started
-
Feb 2021
- Finished
-
Aug 2021
- Lead sponsor
-
A research network
The lead sponsor is a research network or cooperative group.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults residing in nursing homes or attending outpatient healthcare facilities in neighborhoods of selected research sites. Adults and children (\>2 month of age) in neighborhoods of selected research sites.
- Ages
-
2 months and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Adults residing in senior living facilities or attending outpatient healthcare facilities: * At least 18 years of age * Willing and able to provide informed consent or consent has been provided by legal representative (for those with mental incapacity in senior living facilities) * Recruited from a selected facility Adults and children from select neighborhoods of research site communities: * Adults and children \> 2 months of age * For individuals \< 18 years old, a guardian must be present (in person or by phone for those 15 - 17 years old) * Willing and able to provide consent (or assent for individuals 7-17 years old, parent/guardian will provide consent for all minors) * Recruited from a selected venue Exclusion Criteria: * Previous enrollment in this study, either from the same or another CRS community. * Any condition that, in the opinion of the study staff, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Bronx Prevention Center
New York, New York, 10451, United States
-
Children's Hospital Colorado CRS
Aurora, Colorado, 80045, United States
-
Cincinnati CRS
Cincinnati, Ohio, 45229, United States
-
Harlem Prevention
New York, New York, 10027, United States
-
John's Hopkins CRS
Baltimore, Maryland, 21218, United States
-
New Jersey Medical School CRS
Newark, New Jersey, 07103, United States
-
New Orleans Adolescent Trials Unit CRS
New Orleans, Louisiana, 70118, United States
-
Penn Prevention CRS
Philadelphia, Pennsylvania, 19104, United States
-
Physicians & Surgeons CRS
New York, New York, 10032, United States
-
St. Louis University VTEU-CAIMED-PHSU
Ponce, Puerto Rico
-
The Ponce de Leon Center CRS
Atlanta, Georgia, 30308, United States
-
U of Miami, IDRU at Jackson Memorial Hospital CRS
Miami, Florida, 33136, United States
-
UIC Project Wish CRS
Chicago, Illinois, 60612, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A single swab, two diseases: rapid test takes on TB and COVID-19
- A central vault for COVID-19 samples could speed up research
- Can a new vaccine bolster defenses against COVID-19?
- Can new vaccines outsmart COVID-19 variants?
- One shot for two threats: can a single vaccine stop flu and COVID?
- Door-to-Door help may increase COVID testing in Hard-to-Reach communities